Industry NewsNobelpharma signs a license agreement for ProBioGen’s vaccine manufacturing platform AGE1.CR.pIX
Industry NewsValenzaBio partners with ProBioGen to maximize cell line productivity and licenses GlymaxX
Industry NewsHarbour BioMed and ProBioGen agree on a GlymaxX license to fast-track cell line development projects
Industry NewsCRISPR Therapeutics and ProBioGen Collaborate to Develop Novel In Vivo Delivery Technologies
Industry NewsProBioGen and Pionyr Immunotherapeutics Initiate a Second Immuno-Oncology Development Project
Industry NewsProBioGen Will License GlymaxX® to Thermo Fisher Scientific for Use in Developing Allergy Diagnostics
Product NewsProBioGen Launches Unique Portfolio of Engineered High-Performance Cell Lines for Biopharmaceutical Manufacturing
Product NewsProBioGen and Life Technologies Present Freedom<sup>TM</sup> CHO-S<sup>TM</sup> Platform, a Royalty-Free New cGMP Cell Line Development Kit
